البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)
Magnesium sulfate dried; Glycerol; Phenol
Alliance Healthcare (Distribution) Ltd
D11AX05
Magnesium sulfate dried; Glycerol; Phenol
450mg/1gram ; 550mg/1gram ; 5mg/1gram
Cutaneous paste
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13100500
1. TRADE NAME OF THE MEDICINAL PRODUCT Magnesium Sulfate Paste BP 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Name of ingredient Quantity Dried Magnesium Sulfate 47. 762g Phenol 0.497g For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Paste. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an adjunct to the management of superficial skin infections, including boils. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults, elderly and children Apply to the affected area as required. There is no difference in the quantity required for affected areas or for children, adults or the elderly. Stir well before use and apply liberally to the affected area. Cover with a dressing. Method of Administration For topical application 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only. Do not use repeatedly. 4.5. INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION No significant clinical interactions known. 4.6 FERTILITY, PREGNANCY AND LACTATION As with all medicines it may be used during this period if the benefits outweigh the risks. 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES Not applicable. 4.8 UNDESIRABLE EFFECTS None known REPORTING OF SUSPECTED ADVERSE REACTIONS Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard 4.9. OVERDOSE Should accidental ingestion occur, treat symptomatically. 5 PHARMACOLOGICAL PROPERTIES 5.1 PHARMACODYNAMIC PROPERTIES Pharmacotherapeutic Group: Other Dermatologicals, Magnesium Sulfate ATC code: D11A X05 Topical application of the ingredients of the paste help to draw infected wounds and reduce inflammation. 5.2. PHARMACOKINETIC PROPERTIES Not applicable. 5.3. PRE اقرأ الوثيقة كاملة